Intraday Info: Quest Diagnostics Inc (NYSE:DGX) locked on 08/02/2017 at $93.05. It has average volume 915,513 whilst it totals volume 623,835. The company has EPS 4.71 and according to analysts next quarter EPS and next year estimate EPS will 1.18 and 5.78 respectively.
Ownership Summary: Quest Diagnostics Inc has total institutional ownership 88.17% while its total outstanding shares 139 millions that’s value of holdings $11,322 million.
Active Positions: In the latest year, DGX 225 holders have raised its positions while it contains total 8,537,387 shares. And the strength of reduced positions holders and held positions holders are 259 and 127 respectively.
New and Sold Out Positions: In DGX force of new positions holders 52 and it has total shares 2,077,302. And force of sold out positions holders 41 and it has 1,742,010 shares.
Comparison with Other Company: The Market Value of DGX is $ below above from Cigna Corporation market value which is $37M. Current Last Sale of DGX is $93.05 below from CI current last sale which is $147.84.
Quest Diagnostics Inc is operating with Montefiore fitness device (MHS) to offer diagnostic laboratory offerings. This partnership will enhance the exceptional and efficiency of laboratory services at Montefiore.
Quest will carry out a portion of low complexity diagnostic checks at its Teterboro, NJ lab facility. The remainder of the laboratory testing will remain performed at Montefiore Hospitals beneath the direction of the Montefiore and Einstein department of Pathology.
“Quest is a distinct employer devoted to innovating new technology and diagnostic competencies,” stated Philip Ozuah, M.D., Ph.D., and chief running Officer, Montefiore fitness machine. “most significantly, this new challenge will permit Montefiore to preserve its laser consciousness on enhancing affected person care and consequences, at the same time as teaming up with a leader in the field who has get right of entry to the maximum sophisticated diagnostic system available.”